Grants

Federal funding opportunities from Grants.gov — still-open first, soonest deadline at the top.

ArchivedNIH

Mechanistic Studies on Social Behavior in Substance Use Disorder (R01 Clinical Trials Not Allowed)

$425,000
Award ceiling
Jan 29, 2024
Posted
View opportunity →
ArchivedNIH

NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required)

Jan 29, 2024
Posted
View opportunity →
ArchivedNIH

Mechanistic Studies on Social Behavior in Substance Use Disorder (R01 Basic Experimental Studies with Humans (BESH) Required)

Jan 29, 2024
Posted
View opportunity →
ArchivedNIH

NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)

Jan 29, 2024
Posted
View opportunity →
ArchivedNIH

Understanding Mechanisms and Outcomes of Trained Immunity (R21 Clinical Trial Not Allowed)

$275,000
Award ceiling
Jan 25, 2024
Posted
View opportunity →
ArchivedNIH

Novel Approaches for Radiation Biodosimetry Assays and Devices Development (U01 Clinical Trial Not Allowed)

$350,000
Award ceiling
Jan 25, 2024
Posted
View opportunity →
ArchivedNIH

Understanding Mechanisms and Outcomes of Trained Immunity (R01 Clinical Trial Not Allowed)

Jan 25, 2024
Posted
View opportunity →
ArchivedNIH

Notice of Intent to Publish a Funding Opportunity Announcement for Transformative Research to Address Health Disparities and Advance Health Equity (U01 Clinical Trial Optional)

Jan 23, 2024
Posted
View opportunity →
ArchivedNIH

Transformative Research to Address Health Disparities and Advance Health Equity (U01 Clinical Trial Optional)

$500,000
Award ceiling
Jan 23, 2024
Posted
View opportunity →
ArchivedNIH

Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders(U01 Clinical Trial Optional)

Jan 22, 2024
Posted
View opportunity →
ArchivedNIH

Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional)

Jan 22, 2024
Posted
View opportunity →
ArchivedNIH

Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional)

Jan 22, 2024
Posted
View opportunity →